Clinical Trial Update: CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of CHF6563 in babies with Neonatal Opioid Withdrawal Syndrome was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Opioid Withdrawal Syndrome

Drugs mentioned

• CHF6563

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Neonatal Opioid Withdrawal Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2023-08-03